160 related articles for article (PubMed ID: 38655393)
1. Assessing the effectiveness of targeted agents in adjuvant therapy for patients with metastatic colorectal cancer undergoing surgical resection: a retrospective cohort study.
Su YC; Wu CC; Chen YH; Su CC; Chang YC; Hsieh MC; Kao Yang YH
Ther Adv Med Oncol; 2024; 16():17588359241246427. PubMed ID: 38655393
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer.
Wu CC; Su CC; Chen YH; Hsu CW; Chang YC; Su YC
Anticancer Res; 2024 Apr; 44(4):1619-1628. PubMed ID: 38537994
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab.
Bruera G; Cannita K; Giuliante F; Lanfiuti Baldi P; Vicentini R; Marchetti P; Nuzzo G; Antonucci A; Ficorella C; Ricevuto E
Clin Colorectal Cancer; 2012 Jun; 11(2):119-26. PubMed ID: 22206922
[TBL] [Abstract][Full Text] [Related]
4. Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease?
Kataoka K; Kanazawa A; Iwamoto S; Kato T; Nakajima A; Arimoto A
World J Surg; 2014 Apr; 38(4):936-46. PubMed ID: 24166026
[TBL] [Abstract][Full Text] [Related]
5. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with TAS-102 plus bevacizumab in salvage-line treatment of metastatic colorectal cancer: A single-center, retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage-line therapy of metastatic colorectal cancer.
Matsuhashi N; Takahashi T; Fujii H; Suetsugu T; Fukada M; Iwata Y; Tokumaru Y; Imai T; Mori R; Tanahashi T; Matsui S; Imai H; Tanaka Y; Yamaguchi K; Futamura M; Yoshida K
Mol Clin Oncol; 2019 Oct; 11(4):390-396. PubMed ID: 31475067
[TBL] [Abstract][Full Text] [Related]
7. The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.
Poston G; Adam R; Xu J; Byrne B; Esser R; Malik H; Wasan H; Xu J
Eur J Surg Oncol; 2017 Nov; 43(11):2001-2011. PubMed ID: 28927777
[TBL] [Abstract][Full Text] [Related]
8. Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Sabanathan D; Eslick GD; Shannon J
Clin Colorectal Cancer; 2016 Dec; 15(4):e141-e147. PubMed ID: 27174607
[TBL] [Abstract][Full Text] [Related]
9. Effects of the number of neoadjuvant therapy cycles on clinical outcomes, safety, and survival in patients with metastatic colorectal cancer undergoing metastasectomy.
Yeh YS; Tsai HL; Chen YC; Su WC; Chen PJ; Chang TK; Li CC; Huang CW; Wang JY
Oncol Res; 2022; 30(2):65-76. PubMed ID: 37305327
[TBL] [Abstract][Full Text] [Related]
10. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
Gillen S; Schuster T; Meyer Zum Büschenfelde C; Friess H; Kleeff J
PLoS Med; 2010 Apr; 7(4):e1000267. PubMed ID: 20422030
[TBL] [Abstract][Full Text] [Related]
11. Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal Cancer-Predictive Factors and Prognosis.
Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Kaneko M; Murono K
Clin Colorectal Cancer; 2018 Mar; 17(1):e91-e97. PubMed ID: 29113730
[TBL] [Abstract][Full Text] [Related]
12. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
[TBL] [Abstract][Full Text] [Related]
13. Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience.
Joharatnam-Hogan N; Wilson W; Shiu KK; Fusai GK; Davidson B; Hochhauser D; Bridgewater J; Khan K
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261002
[TBL] [Abstract][Full Text] [Related]
14. Rate of Curative Surgery in Real-world Patients with Unresectable Metastatic Colorectal Cancer Treated with FOLFOXIRI ± Bevacizumab: A Western Canadian Province Experience.
Bhatti T; Moser M; Tan KT; Chalchal H; Souied O; Le D; Shaw J; Zaidi A; Gill D; Ahmed S
J Gastrointest Cancer; 2022 Jun; 53(2):427-433. PubMed ID: 33779898
[TBL] [Abstract][Full Text] [Related]
15. Liver resection for colorectal cancer metastases.
Gallinger S; Biagi JJ; Fletcher GG; Nhan C; Ruo L; McLeod RS
Curr Oncol; 2013 Jun; 20(3):e255-65. PubMed ID: 23737695
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer.
Elshenawy MA; Badran A; Aljubran A; Alzahrani A; Rauf MS; Eldali A; Bazarbashi S
World J Surg Oncol; 2020 Jul; 18(1):163. PubMed ID: 32641137
[TBL] [Abstract][Full Text] [Related]
17. Potentially Resectable mCRC-treated with Cetuximab Combined with Chemotherapy.
Kong Y; Hong L; Xu X
J Coll Physicians Surg Pak; 2020 Nov; 30(11):1206-1212. PubMed ID: 33222742
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
[TBL] [Abstract][Full Text] [Related]
19. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
Patel D; Townsend AR; Karapetis C; Beeke C; Padbury R; Roy A; Maddern G; Roder D; Price TJ
Ann Surg Oncol; 2016 Oct; 23(11):3616-3622. PubMed ID: 27251133
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
